Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Multispecific theranostic nano-engager platform

Obiettivo

"This ERC Proof of Concept proposal develops ""Nano-BITE,"" a multifunctional nanoparticle platform addressing limitations of current cancer immunotherapy. Existing bispecific antibodies like blinatumomab suffer from rapid kidney clearance due to small molecular size, requiring continuous intravenous infusion for weeks and showing poor efficacy in solid tumors. The Nano-BITE platform uses PLGA nanoparticles as scaffolds incorporating four integrated features: modular E3/K3 peptide chemistry enabling rapid attachment of nanobodies targeting NK cells and tumor antigens, extended circulation achieving greater than 24-hour half-life versus 7 hours for conventional engagers, localized IL-15 delivery for sustained NK cell activation within tumors without systemic toxicity, and integrated radioisotope chelators enabling PET imaging to track drug distribution and predict response. The platform's innovative ""plug-and-play"" design allows rapid adaptation to different cancers by swapping targeting modules within hours rather than 18-24 months required for new drug development. When imaging reveals antigen switching, subsequent doses can target different antigens using the same nanoparticle backbone. The 18-month validation plan includes optimizing formulation and demonstrating superior NK cell activation in vitro, followed by proving therapeutic efficacy in humanized mouse models of HER2-positive breast cancer. This approach could transform cancer immunotherapy from static treatments to dynamic platforms adapting to disease evolution, potentially capturing markets exceeding fifty billion dollars versus one to five billion for individual bispecifics."

Campo scientifico (EuroSciVoc)

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) ERC-2026-POC

Vedi tutti i progetti finanziati nell’ambito del bando

Istituzione ospitante

INSTITUT GUSTAVE ROUSSY
Contributo netto dell'UE
€ 150 000,00
Indirizzo
Rue Camille Desmoulins 39
94805 Villejuif
Francia
Regione
Ile-de-France Ile-de-France Val-de-Marne
Tipo di attività
Research Organisations
Collegamenti
Costo totale
Nessun dato

Beneficiari (1)